Download PDF
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2019; 77(01): 65
DOI: 10.1590/0004-282X20180152
Letter

Chagas disease, cardioembolic ischemic stroke, INR control and bleeding

Doença de Chagas, acidente vascular cerebral isquêmico cardioembólico, controle de INR e sangramento
Sora Yasr 
1   KMT Primary Care Center, Bangkok, Thailand;
,
Viroj Wiwanitkit
2   Dr DY Patil University, Pune, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Dear Editor,

We read the publication on “Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke” with great interest[1]. Monteiro et al. noted that “Patients with Chagas disease and previous CIS had better control of INR with a higher frequency of minor bleeding [1].” In fact, this finding should be discussed. The important question is: what is the reason for good INR control, but higher frequency of bleeding? The quality control of the INR test should be focused on. An error in laboratory testing may be possible. Several factors can cause the erroneous INR result and need to be well controlled[2]. Also, the bleeding might be due to other non-coagulation factor-related causes. At the least, thrombocytopenia and platelet dysfunction are possible hematological problems in patients with Chagas disease[3],[4]. In addition, Chagas disease can be chronic, despite a complete course of antiparasitic drug treatment, and the platelet dysfunction might be observed in those chronic cases and may manifest the bleeding problem[4].



Publication History

Received: 21 February 2018

Accepted: 15 October 2018

Article published online:
21 August 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Monteiro JMC, San-Martin DL, Silva BCG, Jesus PAP, Oliveira Filho J. Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke. Arq Neuropsiquiatr. 2018 Jan;76(1):22-25. https://doi.org/10.1590/0004-282x20170180
  • 2 Wiwanitkit V. ISO 15189, some comments on its application in the coagulation laboratory. Blood Coagul Fibrinolysis. 2004 Oct;15(7):613-7. https://doi.org/10.1097/00001721-200409000-00013
  • 3 Blevins SM, Greenfield RA, Bronze MS. Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med. 2008 Jul;75(7):521-30.
  • 4 Marcondes MC, Borelli P, Yoshida N, Russo M. Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment. Microbes Infect. 2000 Apr;2(4):347-52. https://doi.org/10.1016/S1286-4579(00)00333-6